Precision Diabetes

Precision Diabetes, Inc. is an emerging leader in enabling precision medicine for diabetes through the use of novel diabetes biomarkers and algorithms.We are the exclusive supplier of the GlycoMark test in the U.S., Europe, Australia, the Asia-Pacific Region, the Middle East, and Mexico. GlycoMark (1,5-Anhydroglucitol) is an FDA-cleared and CE-Marked blood test specific to detecting recent hyperglycemia, glycemic variability, and pancreatic beta-cell mass.